A detailed history of Hrt Financial LP transactions in Bio N Tech Se stock. As of the latest transaction made, Hrt Financial LP holds 3,201 shares of BNTX stock, worth $393,242. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3,201
Holding current value
$393,242
% of portfolio
0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$78.36 - $124.66 $250,830 - $399,036
3,201 New
3,201 $380,000
Q4 2023

Feb 09, 2024

BUY
$90.91 - $112.75 $323,275 - $400,939
3,556 New
3,556 $375,000
Q2 2022

Aug 12, 2022

BUY
$123.25 - $186.24 $477,470 - $721,493
3,874 New
3,874 $577,000

Others Institutions Holding BNTX

About BioNTech SE


  • Ticker BNTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 242,684,992
  • Market Cap $29.8B
  • Description
  • BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...
More about BNTX
Track This Portfolio

Track Hrt Financial LP Portfolio

Follow Hrt Financial LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

News

Stay updated on Hrt Financial LP with notifications on news.